Pyrazolyl quinoxaline kinase inhibitors

Inhibitors of RAS and methods of use thereof

Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists

Imidazolyl tricyclic enones as antioxidant inflammation modulators

C5, C6 substituted and/or fused oxindoles as anti-cancer agents and process for preparation thereof

Ortho-substituted thermally activated delayed fluorescence material and organic light-emitting device comprising same

INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

Substituted Quinoxaline Derivatives

Triazole benzamide derivatives and the compositions and methods of treatment regarding the same

Heterocyclic derivatives modulating activity of certain protein kinases

SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS

BIHETEROARYL COMPOUNDS AND USES THEREOF

Fluorescent organic light emitting elements having high efficiency

Fused azaheterocyclic compounds and their use as AMPA receptor modulators

FYN kinase inhibitors

Amide compounds and method for making and using

Organic electroluminescent materials and devices

PHOSPHOROUS HOST MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME

N-halamine melamine derivatives as novel decontamination and biocidal agents

Heterocyclic amides useful as protein modulators

Pyrazole compounds or salts thereof, preparation methods therefor, herbicidal compositions and use thereof

Substituted benzimidazolium compounds useful in the treatment of respiratory diseases

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

Hepatitis B viral assembly effectors

Compounds and methods for IDO and TDO modulation, and indications therefor

Organometallic compound and organic light-emitting device including the same

SUBSTITUTED N-([1,1'-BIPHENYL]-3-YL)-[1,1'-BIPHENYL]-3-CARBOXAMIDE ANALOGS AS INHIBITORS FOR BETA-CATENIN/B-CELL LYMPHOMA 9 INTERACTIONS

Compositions of protein receptor tyrosine kinase inhibitors

Phosphatidylinositol 3-kinase inhibitors

BIOCIDAL COATINGS AND METHODS FOR MAKING SAME

Indazolones as modulators of tnf signaling

Therapeutic compounds and uses thereof

1-cyano-pyrrolidine compounds as USP30 inhibitors

Composition and method for detecting hypoxia

Compound for organic electronic element, organic electronic element using the same, and electronic device thereof

METHOD OF PREPARATION FOR LEDIPASVIR AND DERIVATIVE THEREOF, AND INTERMEDIATE COMPOUND FOR PREPARATION OF LEDIPASVIR

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

HETEROARYL SYK INHIBITORS

INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS

PHARMACOKINETICALLY IMPROVED COMPOUNDS

Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug

Certain chemical entities, compositions, and methods

Urea compounds containing 3,4-dihydropyrimido[4,5-D]pyrimidin-2(1H)-one skeleton as protein kinase inhibitors

PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS

Organic molecules, especially for use in organic optoelectronic devices

Compositions and methods for inhibiting kinases

Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections

Pyrazolone compound or salt thereof, preparation method therefor, herbicide composition and use thereof

Organic electroluminescent element, electronic device and compound

Pyrrolotriazine inhibitors of IRAK4 activity

Pyridazine derivatives as RORc modulators

Compounds, compositions, and methods

Direct AMPK activators

Heterocyclic compounds and use thereof in medicine and in cosmetics

Biscarbazole derivatives and organic electroluminescence device employing the same

Light-emitting material, and organic electroluminescent device

Heterocyclic compounds and uses thereof

Histone demethylase inhibitors

Lactams as inhibitors of rock

Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

Electronic device containing cyclic lactams

Organic compound and electronic device using same

Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors

Compound, composition, organic electroluminescence element, and electronic device

Heterocyclic compound and organic light emitting device comprising same

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

Selectively substituted quinoline compounds

HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS

Pyridazinone and pyridone compounds

COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE

Carbazole-based gumbos for highly efficient blue OLEDs

Compounds for treatment of complement mediated disorders

Ether compounds for treatment of complement mediated disorders

Process for the alkoxycarbonylation of ethylenically unsaturated compounds with monophosphine ligands

BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS

Autotaxin inhibitors

2,4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARG

Pyridinyl and fused pyridinyl triazolone derivatives

Deuterated organic compound, mixture and composition containing said compound, and organic electronic device

Heterocycle-substituted bicyclic azole pesticides

Bicyclic fused pyrimidine compounds as TAM inhibitors

AN IMPROVED PROCESS FOR THE PREPARATION OF HCV INHIBITOR

Substituted benzimidazolium compounds useful in the treatment of respiratory diseases

Compounds

Heterocyclic compounds and use thereof

Quinazoline and quinoline compounds and uses thereof

Compound for organic optoelectronic diode, organic optoelectronic diode comprising same, and display device

MATERIALS FOR ELECTRONIC DEVICES

Polyurethane-based UV absorber

Heteroaryl compounds as IRAK inhibitors and uses thereof

Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist

Tetrazolones as a carboxylic acid bioisosteres

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as Wnt signaling modulators

Calixpyrrole compounds and creatinine-selective electrodes comprising them

MONOCYCLIC HETEROARYL COMPOUNDS

CARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

COMPOUNDS, COMPOSITIONS, AND METHODS

Pyrimidines as EGFR inhibitors and methods of treating disorders

Substituted 2-anilinopyrimidine derivatives as EGFR modulators

Organic compounds

Small molecule inhibitors of EGFR and PI3K

Substituted heterocycles as bromodomain inhibitors

Organic compounds

AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS

POTASSIUM CHANNEL MODULATORS

Pyrimidine or pyridine compounds, preparation method therefor and pharmaceutical uses thereof

Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer

Ethyldiamine orexin receptor antagonists

HEPATITIS C VIRUS INHIBITOR

Polymorphic forms of methyl((1S)-1-(((2S)-2-(5-(4′-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate and salts thereof

Light emitting electrochemical cells and compounds

Non-nucleoside reverse transcriptase inhibitors

Inhibitors of lysine specific demethylase-1

Inhibitors of lysine specific demethylase-1

Serine/threonine kinase inhibitors

Nitrogen-containing compound and organic electroluminescence device including the same

Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

P2X7 modulators

Plurality of host materials and an organic electroluminescence device comprising the same

EGFR inhibitor compounds

Targeted contrast agents comprising a hydrazide functional group

Pyrazolone compounds having human neutrophil elastase inhibitory properties

Antifungal agents

Light-emitting material, organic light-emitting device, and compound

Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device

Piperidinylpyrazolopyrimidinones and their use

BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY

Pyrazole derivatives as NIK inhibitors

Pyrazole compounds

Process for the purification of the Axl tyrosine receptor kinase inhibitor “R428”

Chimeric compounds targeting proteins, compositions, methods, and uses thereof

Pyrrolobenzodiazepines and conjugates thereof

Quinazoline derivatives substituted by aniline, preparation method and use thereof

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

NON-INVASIVE VENTILATION WITH HIGH FREQUENCY OSCILLATIONS

SOLID FORMS OF AN ANTIVIRAL COMPOUND

Materials for organic electroluminescent devices

Oxygen-containing fused ring amine compound, sulfur-containing fused ring amine compound and organic electroluminescence device

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

Indane inhibitors of EED and methods of their use

Heterocyclic triazole compounds as agonists of the APJ receptor

4-Aminoquinazolin compounds as prolyl hydroxylase inhibitors

Compounds and methods for inhibiting JAK

Amidoethyl azole orexin receptor antagonists

Uracil derivatives as AXL and c-MET kinase inhibitors

Hepatitis C virus inhibitors

Pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto

Compound for organic optoelectric device and organic optoelectric device and display device

GLP-1 receptor modulators

Modulators of calcium release-activated calcium channel

Branched discrete PEG constructs

Therapeutic compounds and uses thereof

A PLURALITY OF HOST MATERIALS AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME

Fluorescent organic light emitting elements having high efficiency

Light extraction substrate, method for manufacturing light extraction substrate, organic electroluminescent element, and method for manufacturing organic electroluminescent element

Pyrimidinone and its derivatives inhibiting factor XIa

Benzimidazole-proline derivatives

BENZYL SUBSTITUTED INDAZOLES AS BUB1 KINASE INHIBITORS

SGC stimulators

QUINAZOLINE DERIVATIVES SUBSTITUTED BY ANILINE, PREPARATION METHOD AND USE THEREOF

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

Amide compounds for treatment of complement mediated disorders

Triazine based radiopharmaceuticals and radioimaging agents

GLS1 inhibitors for treating disease

Substituted pyridine-piperazinyl analogues as RSV antiviral compounds

PYRAZOLE DERIVATIVES AS SGC STIMULATORS

Arylquinazolines

Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

INHIBITORS OF HEPATITIS C VIRUS

Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels

DIAMINOHETEROARYL SUBSTITUTED INDAZOLES

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

AMORPHOUS FORM OF DACLATASVIR AND ITS SALTS AND PROCESS FOR PREPARATION THEREOF

Electron transport materials with selected dipole moments

Pyrrolotriazine compounds as tam inhibitors

Imidazo[4,5-C]pyridine derived SSAO inhibitors

6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists

BENZYL SUBSTITUTED INDAZOLES

BENZYL SUBSTITUTED INDAZOLES AS BUB1 KINASE INHIBITORS

Benzyl substituted indazoles as BUB1 inhibitors

Organic electroluminescent device

Certain protein kinase inhibitors

INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF

Inhibitors of RET

SUBSTITUTED URACILS AS CHYMASE INHIBITORS

Radiohalide-labeled targeted diagnostics and therapeutics

Piperidine derivatives

Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

Alpha-hydroxy-beta-azido-tetrazoles

INHIBITORS FOR STEROID RESPONSE ELEMENTS AND RNA POLYMERASE II AND RELATED METHODS

2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

Quinoxalinones and dihydroquinoxalinones as respiratory syncytial virus ativiral agents

Hepatitis C virus inhibitors and uses thereof in preparation of drugs

N-(hetero)aryl-substituted heteroyclic derivatives useful for the treatment of diseases or conditions related to the central nervous system

Small molecule IRE1-α inhibitors

N4-PHENYL-QUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES

ALK kinase inhibitor, and preparation method and uses thereof

Conjugates of porphyrinoid photosensitizers and glycerol-based polymers for photodynamic therapy

Pyrrolidone derivatives, oligomers and polymers

Methods of treatment of malignancies

2,4-pyrimidinediamine compounds and their uses

ORGANIC LIGHT-EMITTING DIODE MATERIALS

1,4,7,10-tetrazacyclododecane based agents to target bacteria and its use

G protein-coupled receptor kinase 2 inhibitors and methods for use of the same

Azetidinyloxyphenylpyrrolidine compounds

Heterocycle and carbocycle derivatives having TrkA inhibitory activity

Molecular probes for multimodality imaging and tracking of stem cells

Aminopyrimidinyl compounds

Pharmaceutical dosage form for immediate release of an indolinone derivative

Aryl and heteroaryl fused lactams

Quaternary amine compounds and antibody-drug conjugates thereof

Energetic compounds and compositions

Factor D Inhibitors Useful for Treating Inflammatory Disorders

Selective inhibitors of constitutive androstane receptor

Tied-back benzamide derivatives as potent rock inhibitors

Difluoropyrrolidines as orexin receptor modulators

Indoles for use in influenza virus infection

Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

Piperazine derivatives as liver X receptor modulators

Tropomyosin-related kinase (Trk) inhibitors

Materials for electronic devices

Ligand-directed covalent modification of protein

Pyrimidine-2,4-diamine derivatives for treatment of cancer

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

GLP-1 receptor modulators

Compositions and methods for targeting receptors expressed in the gut

Charge-transporting material

Pyrimidine carboxamides as sodium channel blockers

Disulfur bridge linkers for conjugation of a cell-binding molecule

Compositions useful for treating disorders related to kit

Substituted 2-azabicycles and their use as orexin receptor modulators

Alpha-helix analog having triazine-piperazine backbone and method for preparing same

BIOCIDAL COATINGS AND METHODS FOR MAKING SAME

Imidazolyl kinase inhibitors and uses thereof

Disulfur bridge linkers for conjugation of a cell-binding molecule

Electronic device including a fluoranthene derivative

Heterocyclic compounds having cholesterol 24-hydroxylase activity

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof

Process for the preparation of Ledipasvir

Functionalized pegylated cyanine compounds, pharmaceutical compositions, and methods of use thereof

Organic electroluminescent element, method for producing organic electroluminescent element, display, and lighting device

Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors

Benzimidazole retinoic acid receptor-related orphan receptor modulators and uses thereof

Therapeutic compounds and methods of use thereof

Amino compounds for treatment of complement mediated disorders

Substituted indol-5-ol derivatives and their therapeutic applications

Materials for organic light emitting devices

Bis-biotinylation tags

Inhibitors of cyclin-dependent kinase 7 (CDK7)

Heterocyclic amides as kinase inhibitors

Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer

Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors

Inhibitors of bruton's tyrosine kinase

Substituted bicyclic compounds as bromodomain inhibitors

Heterocycle-substituted bicyclic azole pesticides

Quinoxaline compounds and uses thereof

Protein kinase conjugates and inhibitors

Substituted indole Mcl-1 inhibitors

Pyridazine compounds as JAK inhibitors

Heteroaromatic compounds as BTK inhibitors

Inhibitors of the fibroblast growth factor receptor

PRIMARY CARBOXAMIDES AS BTK INHIBITORS

Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule

Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule

Apelin receptor (APJ) agonists and uses thereof

Imidazotriazinone or imidazopyrazinone derivatives, and use thereof

Bicyclic inhibitors of PAD4

2-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin E synthase inhibitors

Five-membered heterocycles useful as serine protease inhibitors

FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS

Organic electroluminescent materials containing benzimidazole and organic electroluminescent device by using the same

Water-soluble activatable molecular probes, intermediates for the synthesis thereof and associated detection methods

TrKA kinase inhibitors, compositions and methods thereof

Histone demethylase inhibitors

Substituted indazole derivatives active as kinase inhibitors

Indazole retinoic acid receptor-related orphan receptor modulators and uses thereof

Cyclopropylamines as LSD1 inhibitors

FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections

Anti-depression compounds

Benzimidazole derivatives as kinase inhibitors

bis-Pyridazine compounds and their use in treating cancer

Pyrazine derivatives

Disulfur bridge linkers for conjugation of a cell-binding molecule

Organic electroluminescence device

Organic electroluminescent compound and an organic electroluminescent device comprising the same

ALKYNYL ALCOHOLS AND METHODS OF USE

Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule

Tetrazole-substituted arylamides as PXand PXantagonists

Organic compound, organic optoelectronic element, and display device

Compositions for electronic devices